German healthcare spending soars:
This article was originally published in Clinica
Germany spent a total of DM 107.5 billion on medical aids, implants, dental replacements, blood products and pharmaceuticals in 1998, an increase of 4.4% over 1996. A further DM 106.7 billion was spent on treatments by medical staff. An estimated DM 5,030 per capita of the population, up DM 70 since 1996. Expenditure within the inpatient sector rose by 3.5% and within the outpatient sector by 2% during this period. Germany has seen an increase of 28.7% in spending within the healthcare sector since 1992. The total expenditure within in the sector in 1998 was DM 412.7 billion, equivalent to 10.9% of GDP.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.